Category Archives: Uncategorized

Collaboration is key to innovation in growing digital health care market

By Omar Ford, Staff Writer ATLANTA – The digital health market is growing. Taking in about $76.7 billion in 2015, the burgeoning space is sustained through partnerships. However, some smaller med-tech companies often have difficulties partnering with larger companies to…

FacebookTwitterGoogle+Share

Device hacking, cybersecurity becoming growing concerns for med-tech companies

By Omar Ford, Staff Writer ATLANTA – Cybersecurity threats are becoming increasingly prevalent in the med-tech industry. Large companies are not immune to these attacks and are in some cases more of a target than smaller firms. Earlier this month…

FacebookTwitterGoogle+Share

Department of Defense awards Memed up to $9.2M to develop point-of-care platform

By Omar Ford, Staff Writer Memed Ltd. has received a contract from the Defense Threat Reduction Agency, a branch of the U.S. Department of Defense (DoD) totaling up to $9.2 million. The contract will help fund the Tirat Carmel, Israel-based…

FacebookTwitterGoogle+Share

BD set to make its biggest med-tech acquisition with $24B C.R. Bard buy

By Omar Ford, Staff Writer Becton, Dickinson and Co. (BD) is set to acquire C.R. Bard Inc. for $24 billion in cash-and-stock. The acquisition values Murray Hill, N.J.-based Bard at $317 per share, a 25 percent premium over Friday’s close…

FacebookTwitterGoogle+Share

Statdx challenges major players in $2B syndromic testing market with Diagcore

By John Brosky, Contributing Writer PARIS – Being first to market does not mean you have won the game. With competition heating up in a new category of in vitro diagnostics (IVDs) called syndromic testing, that lesson is being refreshed…

FacebookTwitterGoogle+Share

Abbott Laboratories doubles first quarter device sales with St. Jude deal closure

By Stacy Lawrence, Staff Writer Abbott Laboratories is aiming to show it’s back on track after a turbulent year working toward two major acquisitions. The Abbott Park, Ill.-based company closed its $25 billion purchase of St. Jude Medical Inc. at…

FacebookTwitterGoogle+Share

J&J on track to match device industry growth rates in 2018 after restructure

By Stacy Lawrence, Staff Writer At the start of 2016, Johnson & Johnson (J&J) undertook a massive restructuring aimed at turning around its medical device business. The New Brunswick, N.J., conglomerate has been gradually swapping in high-growth device businesses and…

FacebookTwitterGoogle+Share

Cardinal Health to acquire portion of Medtronic’s Patient Monitoring & Recovery division for $6.1B

By Omar Ford, Staff Writer Medtronic plc is set to sell its patient care, deep vein thrombosis and nutritional insufficiency businesses within the Patient Monitoring & Recovery (PMR) division of its Minimally Invasive Therapies Group to Dublin, Ohio-based Cardinal Health…

FacebookTwitterGoogle+Share

Myriad study shows discrepancies in Clinvar database for hereditary cancer classification

By Omar Ford, Staff Writer Public genetic databases could have a discrepancy in identifying BRCA1 and BRCA2 variant classifications, which can introduce uncertainty and diminish patient care, according to a study by Myriad Genetics Inc. and researchers from Gradishar from…

FacebookTwitterGoogle+Share

Abbott’s FDA warning on St. Jude Medical problems could lead to product delays

By Stacy Lawrence, Staff Writer The FDA issued an April 12 warning letter to Abbott Laboratories regarding known manufacturing and quality control issues that include a long-nagging cybersecurity one. The problems stem from a February inspection of a Sylmar, Calif.,…

FacebookTwitterGoogle+Share

Marketo